| 101 |
32129745 | [A new generation of immunotherapies targeting the CD39/CD73/adenosine pathway to promote the anti-tumor immune response]. | 2020 Feb |
1 |
| 102 |
32141895 | Erythrocyte adaptive metabolic reprogramming under physiological and pathological hypoxia. | 2020 May |
2 |
| 103 |
32156055 | Opposing Effects of Adenosine and Inosine in Human Subcutaneous Fibroblasts May Be Regulated by Third Party ADA Cell Providers. | 2020 Mar 7 |
2 |
| 104 |
32160899 | Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients. | 2020 Mar 11 |
1 |
| 105 |
32165041 | Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents. | 2020 May 1 |
1 |
| 106 |
32205841 | CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer. | 2020 Mar 23 |
3 |
| 107 |
32212732 | Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73. | 2020 Apr 23 |
1 |
| 108 |
32225110 | Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression. | 2020 Mar 26 |
2 |
| 109 |
32259773 | Adenosine augments the production of IL-10 in cervical cancer cells through interaction with the A2B adenosine receptor, resulting in protection against the activity of cytotoxic T cells. | 2020 Apr 4 |
1 |
| 110 |
32266820 | The expression of CD73 on pathological B-cells is associated with shorter overall survival of patients with CLL. | 2020 Jul |
1 |
| 111 |
32280302 | The yin and yang functions of extracellular ATP and adenosine in tumor immunity. | 2020 |
1 |
| 112 |
32289379 | The TGF-β profibrotic cascade targets ecto-5'-nucleotidase gene in proximal tubule epithelial cells and is a traceable marker of progressive diabetic kidney disease. | 2020 Jul 1 |
3 |
| 113 |
32312837 | Myeloid Cell-Derived TGFβ Signaling Regulates ECM Deposition in Mammary Carcinoma via Adenosine-Dependent Mechanisms. | 2020 Jun 15 |
1 |
| 114 |
32313990 | Apoptotic and anti-proliferative effect of guanosine and guanosine derivatives in HuT-78 T lymphoma cells. | 2020 Jul |
1 |
| 115 |
32344922 | Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes. | 2020 Apr 25 |
2 |
| 116 |
32345959 | Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells. | 2020 Apr 29 |
1 |
| 117 |
32351498 | CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers. | 2020 |
1 |
| 118 |
32363113 | Prognostic value of CD73 expression in resected colorectal cancer liver metastasis. | 2020 |
2 |
| 119 |
32409420 | Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. | 2020 May |
3 |
| 120 |
32417936 | CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model. | 2020 Jun |
1 |
| 121 |
32489531 | CD73+ extracellular vesicles inhibit angiogenesis through adenosine A2B receptor signalling. | 2020 |
1 |
| 122 |
32548862 | CD8+ CD73+ T cells in the tumor microenvironment of head and neck cancer patients are linked to diminished T cell infiltration and activation in tumor tissue. | 2020 Dec |
1 |
| 123 |
32585229 | The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma. | 2020 Sep |
8 |
| 124 |
32614585 | Discovery of AB680: A Potent and Selective Inhibitor of CD73. | 2020 Oct 22 |
4 |
| 125 |
32641760 | Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. | 2020 Sep |
1 |
| 126 |
32643277 | CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer. | 2020 Aug |
1 |
| 127 |
32721947 | Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. | 2020 Sep 3 |
1 |
| 128 |
32739778 | Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation. | 2020 Sep 4 |
4 |
| 129 |
32755765 | Adenosine and adenosine receptors in colorectal cancer. | 2020 Oct |
1 |
| 130 |
32760402 | Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance. | 2020 |
1 |
| 131 |
32786396 | Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39. | 2020 Nov 25 |
1 |
| 132 |
32824670 | Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells. | 2020 Aug 18 |
1 |
| 133 |
32847938 | An IL6-Adenosine Positive Feedback Loop between CD73+ γδTregs and CAFs Promotes Tumor Progression in Human Breast Cancer. | 2020 Oct |
4 |
| 134 |
32865411 | Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production. | 2020 Sep 24 |
9 |
| 135 |
32943546 | Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function. | 2020 Nov |
1 |
| 136 |
32985862 | NMR-Based Assay for the Ex Vivo Determination of Soluble CD73 Activity in Serum. | 2020 Nov 3 |
2 |
| 137 |
33013365 | Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors. | 2020 |
2 |
| 138 |
33045579 | Implications of CD39 in immune-related diseases. | 2020 Dec |
2 |
| 139 |
33072107 | Decreased Frequency of Intestinal CD39+ γδ+ T Cells With Tissue-Resident Memory Phenotype in Inflammatory Bowel Disease. | 2020 |
2 |
| 140 |
33087577 | Extracellular cyclic dinucleotides induce polarized responses in barrier epithelial cells by adenosine signaling. | 2020 Nov 3 |
1 |
| 141 |
33122192 | A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms. | 2020 Dec 25 |
1 |
| 142 |
33123122 | CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells. | 2020 |
1 |
| 143 |
33146056 | Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism. | 2020 Jan-Dec |
2 |
| 144 |
33177176 | Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. | 2020 Nov |
2 |
| 145 |
33187081 | Enzymatic Activity of CD73 Modulates Invasion of Gliomas via Epithelial-Mesenchymal Transition-Like Reprogramming. | 2020 Nov 11 |
2 |
| 146 |
33198064 | Methylation of the NT5E Gene Is Associated with Poor Prognostic Factors in Breast Cancer. | 2020 Nov 12 |
2 |
| 147 |
33214837 | Fluorescent Probes for Ecto-5'-nucleotidase (CD73). | 2020 Nov 12 |
2 |
| 148 |
33322215 | Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study. | 2020 Dec 13 |
1 |
| 149 |
33325366 | [Progress on role of extracellular ATP and its metabolite adenosine in immunoregulation: Review]. | 2020 Dec |
2 |
| 150 |
33335662 | Synthesis, Characterization, and In Silico Studies of Novel Spirooxindole Derivatives as Ecto-5'-Nucleotidase Inhibitors. | 2020 Dec 10 |
1 |